ABOUT THE JOURNAL

Top

Aims and scope of journal

Under the guidance of its respected Editor and expert Editorial Board, Journal of Medical Marketing is the leading international journal for executives performing a marketing or commercial role at every company producing pharmaceuticals, medical devices or diagnostic equipment for the medical industry.

Every quarter, Journal of Medical Marketing publishes a wide range of peer-reviewed practice papers, research articles and professional briefings written by industry experts. Articles focus on the issues of key importance to medical marketers:

  • competitive strategies of leading players in the global market place
  • the impact of emerging market segments
  • alternative strategies for new market entry and existing market share defence
  • product strategies at all stages of the life cycle
  • the effectiveness of traditional and alternative channels of marketing communication
  • the implementation and control of full-mix marketing programmes.
Top

Abstracted/indexed in

Journal of Medical Marketing is abstracted and indexed in:

  • Association of Business Schools' Academic Journal Quality Guide (www.the-abs.org.uk)
  • SCOPUS
Top

ISSN and eISSN

The international standard serial number (ISSN) for Journal of Medical Marketing is 1745-7904 and the electronic international standard serial number (eISSN) is 1745-7912.

Top

Editors

Managing Editor

Dr Leonard Lerer has a wealth of experience in the field, spanning life science investment, pharmaceutical industry strategy and digital technologies. He has advised investors, governments, pharmaceutical companies, multinational corporations, the World Bank and World Health Organization, and is the founder of a company providing specialized analytical marketing services to the pharmaceutical industry. Mr Lerer is a medical doctor with post-graduate qualifications in epidemiology, biostatistics and pathology, and he holds an MBA. He has authored and co-authored over 80 publications. He is currently Senior Research Programme Manager for the Healthcare Management Initiative at INSEAD, Fontainebleau, France.

North American Editor

Dr Peter Dumovic, Head of Medical Information and Communications, US Medical and Drug Regulatory Affairs, Novartis Pharmaceuticals Corporation, USA

European Editor

Dr William Kilgallon, Vice President, Baxter Healthcare, Chicago, USA

Asia/Pacific Editor

Kerry Gilzene, General Manager, DDB Health Asia Pacific, Singapore

Editorial Board

Martin C. Austin, Managing Director, TransformRx GmbH, Switzerland
Professor Bradley R. Barnes, Chair in International Management, Kent Business School, UK
Dr Karel Cool, Professor of Strategy, INSEAD, France
Dr Marc Czarka, Director, Healthcare Consultancy Division, Green Dragon sprl, Belgium
Michael Friedman, Formerly, President and Chief Operating Officer, Purdue Pharma L.P., USA
Mr Michael Frugniet, Head of Business Performance, Marketing Analytics & Capabilities, Region Europe, Novartis Pharma, Swizerland
Alejandro Garcia, Project Leader CRM Real Time, HSBC, Mexico
Dr Dirk Haasner, Head of Regulatory & Medical Affairs, Lundbeck USA, USA
Dr Mathew Joseph, Professor of Marketing and International Business, Mitchell College of Business, University of South Alabama, USA
Dr Christoph Keck, formerly Serono Internaional, Switzerland
Dr Georgios Labiris, Managing Director, Intermedico Network and Lecturer & Senior Research Fellow, Hellenic Open University, Greece
Professor Malcolm McDonald, Emeritus Professor, Cranfield University, UK
Rebecca Robins, Global Marketing Director, Interbrand Wood Healthcare, UK
Dr Brian Smith, Managing Director, PragMedic, UK
Dr Philip Stern, Senior Lecturer, Warwick Business School, UK
Dr Harald Stock, Managing Director, DePuy Germany (a Johnson & Johnson company), Germany
Dr Paul Stuart-Kregor, Director, The MSI Consultancy, UK
Dr Richard Vanderveer, Chairman & Chief Executive Officer, V2 GfK, USA
Dr Bert Tjeenk Willink, President & General Manager, Boehringer Ingelheim Promeco, Mexico
Roland Yap, Executive Director, BioSingapore and Co-Chairman (Asia Pacific Advisory Council) for the Williamsburg BioProcessing Foundation's (WilBio) Asia Pacific BioDevelopment Alliance, (USA)
Dr Christian Zimmermann, International Business Development Manager, Bauerfeind AG, Germany